In the USA, progress has been made in increasing the 5 year survival rate for all stages and forms of pancreatic cancer. In 2002 the 5 year survival rate was approximately 5.5% and in 2022 the rate is 11.5%. That is a doubling of the rate. More progress has been made in the past two decades then several prior decades combined due to drug development, increased funding by the US Federal Government and private sector for pancreatic cancer research, clinical trials, precision medicine and targeted therapy.
PancreaticSurvivor t1_itar61e wrote
Reply to comment by veltcardio2 in Using a gel-like, radioactive implant, engineers have demonstrated the most effective treatment for pancreatic cancer ever recorded in mouse models, the new treatment completely eliminated tumors in 80 percent of mice across several model types, including those considered the most difficult to treat by giuliomagnifico
In the USA, progress has been made in increasing the 5 year survival rate for all stages and forms of pancreatic cancer. In 2002 the 5 year survival rate was approximately 5.5% and in 2022 the rate is 11.5%. That is a doubling of the rate. More progress has been made in the past two decades then several prior decades combined due to drug development, increased funding by the US Federal Government and private sector for pancreatic cancer research, clinical trials, precision medicine and targeted therapy.
https://seer.cancer.gov/statfacts/html/pancreas.html